Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges

References

• Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94(1):155–165. doi:10.1016/j.mayocp.2018.09.013
   PubMed Web of Science ®Google Scholar
• Lightner AL. Stem cell therapy for inflammatory bowel disease. Clin Transl Gastroenterol. 2017;8(3):e82. doi:10.1038/ctg.2017.7
   PubMedGoogle Scholar
• Guan Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019;2019:7247238. doi:10.1155/2019/7247238
   PubMed Web of Science ®Google Scholar
• Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56–66. doi:10.1038/s41575-020-00360-x
   PubMed Web of Science ®Google Scholar
• Coward S, Clement F, Benchimol EI, et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology. 2019;156(5):1345–1353.e1344. doi:10.1053/j.gastro.2019.01.002
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/s0140-6736(17)32448-0
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi:10.1038/nrgastro.2015.150
   PubMed Web of Science ®Google Scholar
• Rogler G, Vavricka S, Schoepfer A, Lakatos PL. Mucosal healing and deep remission: what does it mean? World J Gastroenterol. 2013;19:7552–7560. doi:10.3748/wjg.v19.i43.7552
   PubMed Web of Science ®Google Scholar
• Hommes D, Colombel JF, Emery P, Greco M, Sandborn WJ. Changing Crohn’s disease management: need for new goals and indices to prevent disability and improve quality of life. J Crohns Colitis. 2012;6 Suppl 2:S224–S234. doi:10.1016/s1873-9946(12)60502-9
   PubMed Web of Science ®Google Scholar
• Abraham BP, Ahmed T, Ali T. Inflammatory bowel disease: pathophysiology and current therapeutic approaches. Handb Exp Pharmacol. 2017;239:115–146. doi:10.1007/164_2016_122
   PubMedGoogle Scholar
• Wright EK, Ding NS, Niewiadomski O. Management of inflammatory bowel disease. Med J Aust. 2018;209(7):318–323. doi:10.5694/mja17.01001
   PubMed Web of Science ®Google Scholar
• Zhang HM, Yuan S, Meng H, et al.. Stem cell-based therapies for inflammatory bowel disease. Int J Mol Sci. 2022;23. doi:10.3390/ijms23158494
   Web of Science ®Google Scholar
• Grim C, Noble R, Uribe G, et al. Impairment of tissue-resident mesenchymal stem cells in chronic ulcerative colitis and crohn’s disease. J Crohns Colitis. 2021;15(8):1362–1375. doi:10.1093/ecco-jcc/jjab001
   PubMed Web of Science ®Google Scholar
• Huang Y, Wu Q, Tam PKH. Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci. 2022;23. doi:10.3390/ijms231710023
   Web of Science ®Google Scholar
• Eiro N, Fraile M, González-Jubete A, González LO, Vizoso FJ. Mesenchymal (stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and challenges. Int J Mol Sci. 2022;23(16):8905. doi:10.3390/ijms23168905
   PubMed Web of Science ®Google Scholar
• Mishra R, Dhawan P, Srivastava AS, Singh AB. Inflammatory bowel disease: therapeutic limitations and prospective of the stem cell therapy. World J Stem Cells. 2020;12(10):1050–1066. doi:10.4252/wjsc.v12.i10.1050
   PubMed Web of Science ®Google Scholar
• Che Z, Ye Z, Zhang X, et al. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases. Front Immunol. 2022;13:952071. doi:10.3389/fimmu.2022.952071
   PubMed Web of Science ®Google Scholar
• Artinger KB, Watanabe M. Introduction to “stem cells” special issue. Birth Defects Res. 2022;114:921–925. doi:10.1002/bdr2.2061
   PubMedGoogle Scholar
• Ko JZ-H, Johnson S, Dave M. Efficacy and safety of mesenchymal stem/stromal cell therapy for inflammatory bowel diseases: an up-to-date systematic review. Biomolecules. 2021;11(1):82. doi:10.3390/biom11010082
   PubMed Web of Science ®Google Scholar
• Sherman SE, Agudo J. Immune-mediated specific depletion of intestinal stem cells. Methods Mol Biol. 2020;2171:25–39. doi:10.1007/978-1-0716-0747-3_2
   PubMedGoogle Scholar
• Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013;85(1):3–10. doi:10.1159/000345615
   PubMed Web of Science ®Google Scholar
• Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24(2):98–105. doi:10.1097/JCN.0b013e318197a6a5
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(11):2204–2213. doi:10.1242/jcs.02932
   PubMed Web of Science ®Google Scholar
• Goodell M. Introduction to a review series on hematopoietic stem cells. Blood. 2015;125(17):2587. doi:10.1182/blood-2015-03-615005
   PubMed Web of Science ®Google Scholar
• DiNicola CA, Zand A, Hommes DW. Autologous hematopoietic stem cells for refractory Crohn’s disease. Expert Opin Biol Ther. 2017;17(5):555–564. doi:10.1080/14712598.2017.1305355
   PubMed Web of Science ®Google Scholar
• Ruiz MA, Junior RLK, Piron-Ruiz L, et al. Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn’s disease in Brazil. World J Stem Cells. 2020;12(10):1113–1123. doi:10.4252/wjsc.v12.i10.1113
   PubMed Web of Science ®Google Scholar
• Balassa K, Danby R, Rocha V. Haematopoietic stem cell transplants: principles and indications. Br J Hosp Med. 2019;80(1):33–39. doi:10.12968/hmed.2019.80.1.33
   PubMed Web of Science ®Google Scholar
• Rodríguez-Fuentes DE, Fernández-Garza LE, Samia-Meza JA, et al. Mesenchymal stem cells current clinical applications: a systematic review. Arch Med Res. 2021;52(1):93–101. doi:10.1016/j.arcmed.2020.08.006
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Ding X, Guo J, Tian Z. Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases. Scand J Immunol. 2020;92(3):e12897. doi:10.1111/sji.12897
   PubMed Web of Science ®Google Scholar
• Mao F, Wu Y, Tang X, et al. Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice. Biomed Res Int. 2017;2017:5356760. doi:10.1155/2017/5356760
   PubMed Web of Science ®Google Scholar
• Sarsenova M, Kim Y, Raziyeva K, et al. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Front Immunol. 2022;13:1010399. doi:10.3389/fimmu.2022.1010399
   PubMed Web of Science ®Google Scholar
• de Wolf C, van de Bovenkamp M, Hoefnagel M. Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy. Cytotherapy. 2017;19(7):784–797. doi:10.1016/j.jcyt.2017.03.076
   PubMed Web of Science ®Google Scholar
• Umar S. Intestinal stem cells. Curr Gastroenterol Rep. 2010;12(5):340–348. doi:10.1007/s11894-010-0130-3
   PubMedGoogle Scholar
• Nalapareddy K, Zheng Y, Geiger H. Aging of intestinal stem cells. Stem Cell Rep. 2022;17(4):734–740. doi:10.1016/j.stemcr.2022.02.003
   PubMed Web of Science ®Google Scholar
• Liu J, Walker NM, Cook MT, Ootani A, Clarke LL. Functional Cftr in crypt epithelium of organotypic enteroid cultures from murine small intestine. Am J Physiol Cell Physiol. 2012;302(10):C1492–C1503. doi:10.1152/ajpcell.00392.2011
   PubMed Web of Science ®Google Scholar
• Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev. 2008;22(14):1856–1864. doi:10.1101/gad.1674008
   PubMed Web of Science ®Google Scholar
• Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16(1):19–34. doi:10.1038/s41575-018-0081-y
   PubMed Web of Science ®Google Scholar
• Neal MD, Richardson WM, Sodhi CP, Russo A, Hackam DJ. Intestinal stem cells and their roles during mucosal injury and repair. J Surg Res. 2011;167(1):1–8. doi:10.1016/j.jss.2010.04.037
   PubMed Web of Science ®Google Scholar
• Guiu J, Hannezo E, Yui S, et al. Tracing the origin of adult intestinal stem cells. Nature. 2019;570(7759):107–111. doi:10.1038/s41586-019-1212-5
   PubMed Web of Science ®Google Scholar
• Tan DW, Barker N. Intestinal stem cells and their defining niche. Curr Top Dev Biol. 2014;107:77–107. doi:10.1016/b978-0-12-416022-4.00003-2
   PubMed Web of Science ®Google Scholar
• Jasper H. Intestinal stem cell aging: origins and interventions. Annu Rev Physiol. 2020;82(1):203–226. doi:10.1146/annurev-physiol-021119-034359
   PubMedGoogle Scholar
• Sugimoto S, Sato T. Establishment of 3D intestinal organoid cultures from intestinal stem cells. Methods Mol Biol. 2017;1612:97–105. doi:10.1007/978-1-4939-7021-6_7
   PubMedGoogle Scholar
• Liang R, Xiao X, Luo L, et al. Efficient definitive endoderm differentiation from human parthenogenetic embryonic stem cells induced by activin A and Wnt3a. Ann Clin Lab Sci. 2020;50(4):468–473.
   PubMed Web of Science ®Google Scholar
• Liang R, Wang Z, Kong X, et al. Differentiation of human parthenogenetic embryonic stem cells into functional hepatocyte-like cells. Organogenesis. 2020;16(4):137–148. doi:10.1080/15476278.2020.1848237
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Garitaonandia I, Crain A, et al. Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson’s disease. Cell Transplant. 2015;24(4):681–690. doi:10.3727/096368915x687769
   PubMed Web of Science ®Google Scholar
• Schickl H, Braun M, Dabrock P. Ways out of the patenting prohibition? Human parthenogenetic and induced pluripotent stem cells. Bioethics. 2017;31(5):409–417. doi:10.1111/bioe.12334
   PubMed Web of Science ®Google Scholar
• Ferreira AF, Calin GA, Picanço-Castro V, et al. Hematopoietic stem cells from induced pluripotent stem cells – considering the role of microRNA as a cell differentiation regulator. J Cell Sci. 2018;131(4). doi:10.1242/jcs.203018
   PubMed Web of Science ®Google Scholar
• Soontararak S, Chow L, Johnson V, et al. Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) equivalent to adipose-derived MSC in promoting intestinal healing and microbiome normalization in mouse inflammatory bowel disease model. Stem Cells Transl Med. 2018;7(6):456–467. doi:10.1002/sctm.17-0305
   PubMed Web of Science ®Google Scholar
• Spence JR, Mayhew CN, Rankin SA, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011;470(7332):105–109. doi:10.1038/nature09691
   PubMed Web of Science ®Google Scholar
• Sagi I, Chia G, Golan-Lev T, et al. Derivation and differentiation of haploid human embryonic stem cells. Nature. 2016;532(7597):107–111. doi:10.1038/nature17408
   PubMed Web of Science ®Google Scholar
• Lu Y, Xu Y, Zhang S, et al. Human gingiva-derived mesenchymal stem cells alleviate inflammatory bowel disease via IL-10 signalling-dependent modulation of immune cells. Scand J Immunol. 2019;90(3):e12751. doi:10.1111/sji.12751
   PubMed Web of Science ®Google Scholar
• Otsuka R, Wada H, Murata T, Seino K-I. Immune reaction and regulation in transplantation based on pluripotent stem cell technology. Inflamm Regen. 2020;40(1):12. doi:10.1186/s41232-020-00125-8
   PubMed Web of Science ®Google Scholar
• Cao L, Xu H, Wang G, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization. Int Immunopharmacol. 2019;72:264–274. doi:10.1016/j.intimp.2019.04.020
   PubMed Web of Science ®Google Scholar
• Wang J, Pei B, Yan J, et al. hucMSC-derived exosomes alleviate the deterioration of colitis via the miR-146a/SUMO1 axis. Mol Pharm. 2022;19(2):484–493. doi:10.1021/acs.molpharmaceut.1c00450
   PubMedGoogle Scholar
• Jiang -X-X, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005;105(10):4120–4126. doi:10.1182/blood-2004-02-0586
   PubMed Web of Science ®Google Scholar
• Heidari N, Abbasi‐Kenarsari H, Namaki S, et al. Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by treg cell induction and inflammatory cytokine reduction. J Cell Physiol. 2021;236(8):5906–5920. doi:10.1002/jcp.30275
   PubMed Web of Science ®Google Scholar
• Mounayar M, Kefaloyianni E, Smith B, et al. PI3kα and STAT1 interplay regulates human mesenchymal stem cell immune polarization. Stem Cells. 2015;33(6):1892–1901. doi:10.1002/stem.1986
   PubMed Web of Science ®Google Scholar
• Qin Z, Wang P-Y, Wan -J-J, et al. MicroRNA124-IL6R mediates the effect of nicotine in inflammatory bowel disease by shifting Th1/Th2 balance toward Th1. Front Immunol. 2020;11:235. doi:10.3389/fimmu.2020.00235
   PubMed Web of Science ®Google Scholar
• Terraza-Aguirre C, Campos-Mora M, Elizondo-Vega R, et al. Mechanisms behind the immunoregulatory dialogue between mesenchymal stem cells and Th17 cells. Cells. 2020;9(7):1660. doi:10.3390/cells9071660
   PubMed Web of Science ®Google Scholar
• Reis M, Mavin E, Nicholson L, et al. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function. Front Immunol. 2018;9:2538. doi:10.3389/fimmu.2018.02538
   PubMed Web of Science ®Google Scholar
• Qian X, An N, Ren Y, et al. Immunosuppressive effects of mesenchymal stem cells-derived exosomes. Stem Cell Rev Rep. 2021;17(2):411–427. doi:10.1007/s12015-020-10040-7
   PubMed Web of Science ®Google Scholar
• Song W-J, Li Q, Ryu M-O, et al. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice. Res Vet Sci. 2019;125:176–184. doi:10.1016/j.rvsc.2019.06.012
   PubMed Web of Science ®Google Scholar
• Li Y, Ma K, Zhang L, Xu H, Zhang N. Human umbilical cord blood derived-mesenchymal stem cells alleviate dextran sulfate sodium-induced colitis by increasing regulatory T cells in mice. Front Cell Dev Biol. 2020;8:604021. doi:10.3389/fcell.2020.604021
   PubMed Web of Science ®Google Scholar
• Cao X, Duan L, Hou H, et al. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE 2 -mediated M2 macrophage polarization. Theranostics. 2020;10(17):7697–7709. doi:10.7150/thno.45434
   PubMed Web of Science ®Google Scholar
• García JR, Quirós M, Han WM, et al. IFN-γ-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair. Biomaterials. 2019;220:119403. doi:10.1016/j.biomaterials.2019.119403
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009–1016. doi:10.1038/ni.3002
   PubMed Web of Science ®Google Scholar
• Yang J, Liu XX, Fan H, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis. PLoS One. 2015;10(10):e0140551. doi:10.3389/fimmu.2022.952071
   PubMed Web of Science ®Google Scholar
• Rager TM, Olson JK, Zhou Y, Wang Y, Besner GE. Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis. J Pediatr Surg. 2016;51(6):942–947. doi:10.1016/j.jpedsurg.2016.02.061
   PubMed Web of Science ®Google Scholar
• Liang X, Zhang L, Wang S, Han Q, Zhao RC. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci. 2016;129(11):2182–2189. doi:10.1242/jcs.170373
   PubMed Web of Science ®Google Scholar
• Wang X, Wang H, Cao J, Ye C. Exosomes from adipose-derived stem cells promotes VEGF-C-dependent lymphangiogenesis by regulating miRNA-132/TGF-β pathway. Cell Physiol Biochem. 2018;49:160–171. doi:10.1159/000492851
   PubMedGoogle Scholar
• Guillén MI, Platas J, Pérez Del Caz MD, Mirabet V, Alcaraz MJ. Paracrine anti-inflammatory effects of adipose tissue-derived mesenchymal stem cells in human monocytes. Front Physiol. 2018;9:661. doi:10.3389/fphys.2018.00661
   PubMed Web of Science ®Google Scholar
• Komori M, Tsuji S, Tsujii M, et al. Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen. 2005;13:109–118. doi:10.1111/j.1067-1927.2005.130114.x
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Tsuji S, Tsujii M, et al. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J Pharmacol Exp Ther. 2008;326:523–531. doi:10.1124/jpet.108.137083
   PubMed Web of Science ®Google Scholar
• Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol. 2021;47:254–273. doi:10.1080/1040841x.2021.1876631
   PubMed Web of Science ®Google Scholar
• Bailey CC, Zhong G, Huang IC, Farzan M. IFITM-family proteins: the cell’s first line of antiviral defense. Annu Rev Virol. 2014;1:261–283. doi:10.1146/annurev-virology-031413-085537
   PubMed Web of Science ®Google Scholar
• Yagi H, Chen AF, Hirsch D, et al. Antimicrobial activity of mesenchymal stem cells against Staphylococcus aureus. Stem Cell Res Ther. 2020;11:293. doi:10.1186/s13287-020-01807-3
   PubMed Web of Science ®Google Scholar
• Alcayaga-Miranda F, Cuenca J, Martin A, et al. Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis. Stem Cell Res Ther. 2015;6:199. doi:10.1186/s13287-015-0192-0
   PubMed Web of Science ®Google Scholar
• Yang R, Liu Y, Kelk P, et al. A subset of IL-17(+) mesenchymal stem cells possesses anti-Candida albicans effect. Cell Res. 2013;23:107–121. doi:10.1038/cr.2012.179
   PubMed Web of Science ®Google Scholar
• Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology. 2006;130(7):2060–2073. doi:10.1053/j.gastro.2006.03.054
   PubMed Web of Science ®Google Scholar
• Manieri NA, Mack MR, Himmelrich MD, et al. Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis. J Clin Invest. 2015;125:3606–3618. doi:10.1172/jci81423
   PubMed Web of Science ®Google Scholar
• Tao H, Han Z, Han ZC, Li Z. Proangiogenic features of mesenchymal stem cells and their therapeutic applications. Stem Cells Int. 2016;2016:1314709. doi:10.1155/2016/1314709
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Yang M, et al. Efficient differentiation of bone marrow mesenchymal stem cells into endothelial cells in vitro. Eur J Vasc Endovasc Surg. 2018;55(2):257–265. doi:10.1016/j.ejvs.2017.10.012
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang B, Jin T, et al. Intestinal fibrosis in inflammatory bowel disease and the prospects of mesenchymal stem cell therapy. Front Immunol. 2022;13:835005. doi:10.3389/fimmu.2022.835005
   PubMed Web of Science ®Google Scholar
• Lovisa S, Genovese G, Danese S. Role of epithelial-to-mesenchymal transition in inflammatory bowel disease. J Crohns Colitis. 2019;13(5):659–668. doi:10.1093/ecco-jcc/jjy201
   PubMed Web of Science ®Google Scholar
• Lian L, Huang Q, Zhang L, et al. Anti-fibrogenic potential of mesenchymal stromal cells in treating fibrosis in crohn’s disease. Dig Dis Sci. 2018;63(7):1821–1834. doi:10.1007/s10620-018-5082-8
   PubMed Web of Science ®Google Scholar
• Choi YJ, Koo JB, Kim HY, et al. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A. Stem Cell Res Ther. 2019;10(1):291. doi:10.1186/s13287-019-1385-8
   PubMed Web of Science ®Google Scholar
• Srivastava AS, Feng Z, Mishra R, et al. Embryonic stem cells ameliorate piroxicam-induced colitis in IL10−/− KO mice. Biochem Biophys Res Commun. 2007;361(4):953–959. doi:10.1016/j.bbrc.2007.07.139
   PubMed Web of Science ®Google Scholar
• Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132(4):661–680. doi:10.1016/j.cell.2008.02.008
   PubMed Web of Science ®Google Scholar
• Wang M, Cai J, Huang F, et al. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells. Int J Mol Med. 2015;35(2):367–375. doi:10.3892/ijmm.2014.2019
   PubMed Web of Science ®Google Scholar
• Zheng X-B, He X-W, Zhang L-J, et al. Bone marrow-derived CXCR4-overexpressing MSCs display increased homing to intestine and ameliorate colitis-associated tumorigenesis in mice. Gastroenterol Rep. 2019;7(2):127–138. doi:10.1093/gastro/goy017
   Google Scholar
• He R, Han C, Li Y, Qian W, Hou X. Cancer-preventive role of bone marrow-derived mesenchymal stem cells on colitis-associated colorectal cancer: roles of gut microbiota involved. Front Cell Dev Biol. 2021;9:642948. doi:10.3389/fcell.2021.642948
   PubMed Web of Science ®Google Scholar
• Koh GY, Kane A, Lee K, et al. Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice. Int J Cancer. 2018;143(7):1797–1805. doi:10.1002/ijc.31559
   PubMed Web of Science ®Google Scholar
• Zhang X, Hu X, Rao X. Apoptosis induced by Staphylococcus aureus toxins. Microbiol Res. 2017;205:19–24. doi:10.1016/j.micres.2017.08.006
   PubMed Web of Science ®Google Scholar
• Nakatsuji T, Chen TH, Butcher AM, et al. A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Science Adv. 2018;4(2):eaao4502. doi:10.1126/sciadv.aao4502
   PubMed Web of Science ®Google Scholar
• Wang LT, Liu KJ, Sytwu HK, Yen ML, Yen BL. Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med. 2021;10:1288–1303. doi:10.1002/sctm.21-0021
   PubMed Web of Science ®Google Scholar
• Shi MY, Liu L, Yang FY. Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease. World J Stem Cells. 2022;14:684–699. doi:10.4252/wjsc.v14.i9.684
   PubMed Web of Science ®Google Scholar
• Banerjee A, Bizzaro D, Burra P, et al. Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice. Stem Cell Res Ther. 2015;6(1):79. doi:10.1186/s13287-015-0073-6
   PubMedGoogle Scholar
• Robinson AM, Miller S, Payne N, et al. Neuroprotective potential of mesenchymal stem cell-based therapy in acute stages of TNBS-induced colitis in guinea-pigs. PLoS One. 2015;10(9):e0139023. doi:10.1371/journal.pone.0139023
   PubMed Web of Science ®Google Scholar
• Xie M, Qin H, Luo Q, et al. Comparison of adipose-derived and bone marrow mesenchymal stromal cells in a murine model of crohn’s disease. Dig Dis Sci. 2017;62(1):115–123. doi:10.1007/s10620-016-4166-6
   PubMed Web of Science ®Google Scholar
• Qu B, Xin G-R, Zhao L-X, et al. Testing stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regeneration. PLoS One. 2014;9(10):e107891. doi:10.1371/journal.pone.0107891
   PubMed Web of Science ®Google Scholar
• Watanabe M. Retraction: adult tissue stem cell therapy for gastrointestinal diseases by Mamoru Watanabe. J Gastroenterol Hepatol. 2018;33(1):329. doi:10.1111/jgh.12555
   PubMedGoogle Scholar
• Fukuda M, Mizutani T, Mochizuki W, et al. Small intestinal stem cell identity is maintained with functional Paneth cells in heterotopically grafted epithelium onto the colon. Genes Dev. 2014;28(16):1752–1757. doi:10.1101/gad.245233.114
   PubMed Web of Science ®Google Scholar
• Shaker A, Rubin DC. Stem cells: one step closer to gut repair. Nature. 2012;485(7397):181–182. doi:10.1038/485181a
   PubMed Web of Science ®Google Scholar
• Watanabe S, Kobayashi S, Ogasawara N, et al. Transplantation of intestinal organoids into a mouse model of colitis. Nat Protoc. 2022;17(3):649–671. doi:10.1038/s41596-021-00658-3
   PubMed Web of Science ®Google Scholar
• Burt RK, Craig RM, Milanetti F, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood. 2010;116(26):6123–6132. doi:10.1182/blood-2010-06-292391
   PubMed Web of Science ®Google Scholar
• Cassinotti A, Annaloro C, Ardizzone S, et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s disease. Gut. 2008;57(2):211–217. doi:10.1136/gut.2007.128694
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Allez M, Clark MM, et al. Autologous hematopoetic stem cell transplantation for refractory Crohn Disease: a randomized clinical trial. JAMA. 2015;314(23):2524–2534. doi:10.1001/jama.2015.16700
   PubMed Web of Science ®Google Scholar
• Bislenghi G, Wolthuis A, Van Assche G, et al. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease. Expert Opin Biol Ther. 2019;19(7):607–616. doi:10.1080/14712598.2019.1623876
   PubMed Web of Science ®Google Scholar
• Panes J, García-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a Phase 3 randomised, double-blind controlled trial. Lancet. 2016;388(10051):1281–1290. doi:10.1016/S0140-6736(16)31203-X
   PubMed Web of Science ®Google Scholar
• García-Olmo D, García-Arranz M, Herreros D, et al. A Phase I clinical trial of the treatment of Crohn’s Fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48(7):1416–1423. doi:10.1007/s10350-005-0052-6
   PubMed Web of Science ®Google Scholar
• Zhang J, Lv S, Liu X, Song B, Shi L. Umbilical cord mesenchymal stem cell treatment for Crohn’s disease: a randomized controlled clinical trial. Gut Liver. 2018;12(1):73–78. doi:10.5009/gnl17035
   PubMed Web of Science ®Google Scholar
• Forbes GM, Sturm MJ, Leong RW, et al. A Phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 2014;12(1):64–71. doi:10.1016/j.cgh.2013.06.021
   PubMed Web of Science ®Google Scholar
• Knyazev OV, Kagramanova AV, Fadeeva NA, et al. Mesenchymal stromal cells of bone marrow and azathioprine in Crohn’s disease therapy. Ter Arkh. 2018;90(2):47–52. doi:10.26442/terarkh201890247-52
   PubMed Web of Science ®Google Scholar
• Seo Y, Kang M-J, Kim H-S. Strategies to potentiate paracrine therapeutic efficacy of mesenchymal stem cells in inflammatory diseases. Int J Mol Sci. 2021;22(7):3397. doi:10.3390/ijms22073397
   PubMed Web of Science ®Google Scholar
• Lucafò M, Muzzo A, Marcuzzi M, et al. Patient-derived organoids for therapy personalization in inflammatory bowel diseases. World J Gastroenterol. 2022;28(24):2636–2653. doi:10.3748/wjg.v28.i24.2636
   PubMed Web of Science ®Google Scholar
• Arjmand B, Rabbani Z, Soveyzi F, et al.. Advancement of organoid technology in regenerative medicine. Regen Eng Transl Med. 2022:1–14. doi:10.1007/s40883-022-00271-0
   Web of Science ®Google Scholar
• Lopez-Santalla M, Garin MI. Improving the efficacy of mesenchymal stem/stromal-based therapy for treatment of inflammatory bowel diseases. Biomedicines. 2021;9(11):1507. doi:10.3390/biomedicines9111507
   PubMed Web of Science ®Google Scholar
• Petrenko Y, Syková E, Kubinová Š. The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids. Stem Cell Res Ther. 2017;8(1):94. doi:10.1186/s13287-017-0558-6
   PubMedGoogle Scholar
• Chen Y, Shu Z, Qian K, Wang J, Zhu H. Harnessing the properties of biomaterial to enhance the immunomodulation of mesenchymal stem cells. Tissue Eng Part B Rev. 2019;25(6):492–499. doi:10.1089/ten.TEB.2019.0131
   PubMed Web of Science ®Google Scholar
• Hanson SE, King SN, Kim J, et al. The effect of mesenchymal stromal cell–hyaluronic acid hydrogel constructs on immunophenotype of macrophages. Tissue Eng Part A. 2011;17(19–20):2463–2471. doi:10.1089/ten.TEA.2010.0716
   PubMed Web of Science ®Google Scholar
• Li H, Shen S, Fu H, et al. Immunomodulatory functions of mesenchymal stem cells in tissue engineering. Stem Cells Int. 2019;2019:9671206. doi:10.1155/2019/9671206
   PubMed Web of Science ®Google Scholar
• Kang JY, Oh M-K, Joo H, et al. Xeno-free condition enhances therapeutic functions of human Wharton’s Jelly-derived mesenchymal stem cells against experimental colitis by upregulated indoleamine 2,3-dioxygenase activity. J Clin Med. 2020;9(9):2913. doi:10.3390/jcm9092913
   PubMed Web of Science ®Google Scholar
• Wu X, Wu D, Mu Y, Zhao Y, Ma Z. Serum-free medium enhances the therapeutic effects of umbilical cord mesenchymal stromal cells on a murine model for acute colitis. Front Bioeng Biotechnol. 2020;8:586. doi:10.3389/fbioe.2020.00586
   PubMed Web of Science ®Google Scholar
• Liu Y, Xiao F, Hu X, et al. Recovery and maintenance of NESTIN expression in umbilical cord-MSC using a novel culture medium. AMB Express. 2020;10(1):132. doi:10.1186/s13568-020-01067-7
   PubMed Web of Science ®Google Scholar
• Salmenkari H, Laitinen A, Forsgård RA, et al. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study. Cytotherapy. 2019;21(2):175–188. doi:10.1016/j.jcyt.2018.11.011
   PubMed Web of Science ®Google Scholar
• Shin T-H, Ahn J-S, Oh S-J, et al. TNF-α priming elicits robust immunomodulatory potential of human tonsil-derived mesenchymal stem cells to alleviate murine colitis. Biomedicines. 2020;8(12):561. doi:10.3390/biomedicines8120561
   PubMed Web of Science ®Google Scholar
• Yu D, Zhao Y, Wang H, et al. IL-1β pre-stimulation enhances the therapeutic effects of endometrial regenerative cells on experimental colitis. Stem Cell Res Ther. 2021;12(1):324. doi:10.1186/s13287-021-02392-9
   PubMed Web of Science ®Google Scholar
• Payne NL, Dantanarayana A, Sun G, et al. Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination. Cell Adh Migr. 2012;6(3):179–189. doi:10.4161/cam.20341
   PubMed Web of Science ®Google Scholar
• Song SY, Hong J, Go S, et al. Interleukin-4 gene transfection and spheroid formation potentiate therapeutic efficacy of mesenchymal stem cells for osteoarthritis. Adv Healthcare Mater. 2020;9(5):e1901612. doi:10.1002/adhm.201901612
   Web of Science ®Google Scholar
• Wang W-Q, Dong K, Zhou L, et al. IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice. Acta Pharmacol Sin. 2015;36(11):1377–1387. doi:10.1038/aps.2015.51
   PubMed Web of Science ®Google Scholar
• Nan Z, Fan H, Tang Q, et al. Dual expression of CXCR4 and IL-35 enhances the therapeutic effects of BMSCs on TNBS-induced colitis in rats through expansion of tregs and suppression of Th17 cells. Biochem Biophys Res Commun. 2018;499(4):727–734. doi:10.1016/j.bbrc.2018.03.043
   PubMed Web of Science ®Google Scholar
• Fu Y, Ni J, Chen J, et al. Dual-functionalized MSCs that express CX3CR1 and IL-25 exhibit enhanced therapeutic effects on inflammatory bowel disease. Mol Ther. 2020;28(4):1214–1228. doi:10.1016/j.ymthe.2020.01.020
   PubMed Web of Science ®Google Scholar
• Liu L, Wang Y, Fan H, et al. MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells. Stem Cells. 2012;30(8):1756–1770. doi:10.1002/stem.1156
   PubMed Web of Science ®Google Scholar
• Lu Q, Chen R, Du S, et al. Activation of the cGAS-STING pathway combined with CRISPR-Cas9 gene editing triggering long-term immunotherapy. Biomaterials. 2022;291:121871. doi:10.1016/j.biomaterials.2022.121871
   PubMed Web of Science ®Google Scholar
• Crippa S, Conti A, Vavassori V, et al. Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. Mol Ther. 2022;30(10):3333. doi:10.1016/j.ymthe.2022.09.005
   PubMed Web of Science ®Google Scholar
• Chen Q, Li Y, Chen Z, Du H, Wan J. Anti-VCAM 1 antibody-coated mesenchymal stromal cells attenuate experimental colitis via immunomodulation. Med Sci Monit. 2019;25:4457–4468. doi:10.12659/msm.914238
   PubMed Web of Science ®Google Scholar
• Ko IK, Kim B-G, Awadallah A, et al. Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther. 2010;18(7):1365–1372. doi:10.1038/mt.2010.54
   PubMed Web of Science ®Google Scholar
• Li X, Lan X, Zhao Y, et al. SDF-1/CXCR4 axis enhances the immunomodulation of human endometrial regenerative cells in alleviating experimental colitis. Stem Cell Res Ther. 2019;10(1):204. doi:10.1186/s13287-019-1298-6
   PubMedGoogle Scholar
• Li X, Wang Q, Ding L, et al. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens. Stem Cell Res Ther. 2019;10(1):267. doi:10.1186/s13287-019-1384-9
   PubMed Web of Science ®Google Scholar
• Robinson AM, Sakkal S, Park A, et al. Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2014;307(11):G1115–G1129. doi:10.1152/ajpgi.00174.2014
   PubMed Web of Science ®Google Scholar
• Heidari M, Pouya S, Baghaei K, et al. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. J Cell Physiol. 2018;233:8754–8766. doi:10.1002/jcp.26765
   PubMed Web of Science ®Google Scholar
• Lykov AP, Poveshchenko OV, Bondarenko NA, et al. Therapeutic potential of biomedical cell product in DSS-induced inflammation in the small intestine of C57Bl/6J mice. Bull Exp Biol Med. 2018;165:576–580. doi:10.1007/s10517-018-4216-5
   PubMed Web of Science ®Google Scholar
• Lee KE, Jung S-A, Joo Y-H, et al. The efficacy of conditioned medium released by tonsil-derived mesenchymal stem cells in a chronic murine colitis model. PLoS One. 2019;14(12):e0225739. doi:10.1371/journal.pone.0225739
   PubMed Web of Science ®Google Scholar
• Yang S, Liang X, Song J, et al. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther. 2021;12:315. doi:10.1186/s13287-021-02404-8
   PubMed Web of Science ®Google Scholar
• Barnhoorn MC, Wasser MN, Roelofs H, et al. Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for crohn’s disease perianal fistulas. J Crohns Colitis. 2020;14:64–70. doi:10.1093/ecco-jcc/jjz116
   PubMed Web of Science ®Google Scholar
• Chao K, Zhang S, Qiu Y, et al. Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells. Stem Cell Res Ther. 2016;7:109. doi:10.1186/s13287-016-0376-2
   PubMed Web of Science ®Google Scholar
• Legaki E, Roubelakis MG, Theodoropoulos GE, et al. Therapeutic potential of secreted molecules derived from human amniotic fluid mesenchymal stem/stroma cells in a mice model of colitis. Stem Cell Rev Rep. 2016;12(5):604–612. doi:10.1007/s12015-016-9677-1
   PubMed Web of Science ®Google Scholar
• de Aguiar CF, Castoldi A, Andrade-Oliveira V, et al. Mesenchymal stromal cells modulate gut inflammation in experimental colitis. Inflammopharmacology. 2018;26(1):251–260. doi:10.1007/s10787-017-0404-6
   PubMed Web of Science ®Google Scholar
• de la Portilla F, Alba F, García-Olmo D, et al. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis. 2013;28:313–323. doi:10.1007/s00384-012-1581-9
   PubMed Web of Science ®Google Scholar
• de la Portilla F, Yuste Y, Pereira S, et al. Local mesenchymal stem cell therapy in experimentally induced colitis in the rat. Int J Stem Cell. 2018;11(1):39–47. doi:10.15283/ijsc17074
   PubMed Web of Science ®Google Scholar
• Fu ZW, Zhang ZY, Ge HY. Mesenteric injection of adipose-derived mesenchymal stem cells relieves experimentally-induced colitis in rats by regulating Th17/Treg cell balance. Am J Transl Res. 2018;10:54–66.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rey E, Anderson P, Gonzalez MA, et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 2009;58(7):929–939. doi:10.1136/gut.2008.168534
   PubMed Web of Science ®Google Scholar
• Gregoire C, Briquet A, Pirenne C, et al. Allogeneic mesenchymal stromal cells for refractory luminal Crohn’s disease: a Phase I–II study. Dig Liver Dis. 2018;50(11):1251–1255. doi:10.1016/j.dld.2018.08.015
   PubMedGoogle Scholar
• Hu J, Zhao G, Zhang L, et al. Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp Ther Med. 2016;12(5):2983–2989. doi:10.3892/etm.2016.3724
   PubMed Web of Science ®Google Scholar
• Lee HJ, Oh S-H, Jang HW, et al. Long-term effects of bone marrow-derived mesenchymal stem cells in dextran sulfate sodium-induced murine chronic colitis. Gut Liver. 2016;10(3):412–419. doi:10.5009/gnl15229
   PubMed Web of Science ®Google Scholar
• Lee B-C, Shin N, Lee JY, et al. MIS416 enhances therapeutic functions of human umbilical cord blood-derived mesenchymal stem cells against experimental colitis by modulating systemic immune milieu. Front Immunol. 2018;9:1078. doi:10.3389/fimmu.2018.01078
   PubMed Web of Science ®Google Scholar
• Panés J, García-Olmo D, Van Assche G, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2018;154(5):1334–1342.e1334. doi:10.1053/j.gastro.2017.12.020
   PubMed Web of Science ®Google Scholar
• Martín Arranz E, Martín Arranz MD, Robredo T, et al. Endoscopic submucosal injection of adipose-derived mesenchymal stem cells ameliorates TNBS-induced colitis in rats and prevents stenosis. Stem Cell Res Ther. 2018;9(1):95. doi:10.1186/s13287-018-0837-x
   PubMedGoogle Scholar
• Miyamoto S, Ohnishi S, Onishi R, et al. Therapeutic effects of human amnion-derived mesenchymal stem cell transplantation and conditioned medium enema in rats with trinitrobenzene sulfonic acid-induced colitis. Am J Transl Res. 2017;9(3):940–952.
   PubMed Web of Science ®Google Scholar
• Molendijk I, Bonsing BA, Roelofs H, et al. Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2015;149(4):918–927.e916. doi:10.1053/j.gastro.2015.06.014
   PubMed Web of Science ®Google Scholar
• Pak S, Hwang SW, Shim IK, et al. Endoscopic transplantation of mesenchymal stem cell sheets in experimental colitis in rats. Sci Rep. 2018;8(1):11314. doi:10.1038/s41598-018-29617-x
   PubMedGoogle Scholar
• Park S-R, Kim J-W, Jun H-S, et al. Stem cell secretome and its effect on cellular mechanisms relevant to wound healing. Mol Ther. 2018;26(2):606–617. doi:10.1016/j.ymthe.2017.09.023
   PubMed Web of Science ®Google Scholar
• Pouya S, Heidari M, Baghaei K, et al. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol. 2018;54:86–94. doi:10.1016/j.intimp.2017.11.001
   PubMed Web of Science ®Google Scholar
• Song J-Y, Kang HJ, Hong JS, et al. Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep. 2017;7(1):9412. doi:10.1038/s41598-017-09827-5
   PubMedGoogle Scholar
• Song W-J, Li Q, Ryu M-O, et al. TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice. Stem Cell Res Ther. 2018;9(1):91. doi:10.1186/s13287-018-0841-1
   PubMed Web of Science ®Google Scholar
• Tanaka F, Tominaga K, Ochi M, et al. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. 2008;83(23–24):771–779. doi:10.1016/j.lfs.2008.09.016
   PubMed Web of Science ®Google Scholar
• Wu Y, Qiu W, Xu X, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease in mice through ubiquitination. Am J Transl Res. 2018;10(7):2026–2036.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang Y, Zhang B, et al. Treatment of experimental colitis by endometrial regenerative cells through regulation of B lymphocytes in mice. Stem Cell Res Ther. 2018;9(1):146. doi:10.1186/s13287-018-0874-5
   PubMedGoogle Scholar
• Yu Y, Song EM, Lee KE, et al. Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis. PLoS One. 2017;12(8):e0183141. doi:10.1371/journal.pone.0183141
   PubMed Web of Science ®Google Scholar
• Oyama Y, Craig RM, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology. 2005;128(3):552–563. doi:10.1053/j.gastro.2004.11.051
   PubMed Web of Science ®Google Scholar
• Clerici M, Cassinotti A, Onida F, et al. Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn’s disease. Dig Liver Dis. 2011;43(12):946–952. doi:10.1016/j.dld.2011.07.021
   PubMedGoogle Scholar
• Hasselblatt P, Drognitz K, Potthoff K, et al. Remission of refractory Crohn’s disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther. 2012;36(8):725–735. doi:10.1111/apt.12032
   PubMed Web of Science ®Google Scholar
• Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143(2):347–355. doi:10.1053/j.gastro.2012.04.045
   PubMed Web of Science ®Google Scholar
• Liang J, Zhang H, Wang D, et al. Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease. Gut. 2012;61(3):468–469. doi:10.1136/gutjnl-2011-300083
   PubMed Web of Science ®Google Scholar
• Garca-Olmo D, García-Arranz M, García LG, et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy. Int J Colorectal Dis. 2003;18(5):451–454. doi:10.1007/s00384-003-0490-3
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009;52(1):79–86. doi:10.1007/DCR.0b013e3181973487
   PubMed Web of Science ®Google Scholar
• Guadalajara H, Herreros D, De-La-Quintana P, et al. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis. 2012;27(5):595–600. doi:10.1007/s00384-011-1350-1
   PubMed Web of Science ®Google Scholar
• Herreros MD, Garcia-Arranz M, Guadalajara H, De-La-Quintana P, Garcia-Olmo D. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula advanced therapy trial 1) and long-term evaluation. Dis Colon Rectum. 2012;55(7):762–772. doi:10.1097/DCR.0b013e318255364a
   PubMed Web of Science ®Google Scholar
• Dietz AB, Dozois EJ, Fletcher JG, et al. Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2017;153(1):59–62.e52. doi:10.1053/j.gastro.2017.04.001
   PubMed Web of Science ®Google Scholar
• Dige A, Hougaard HT, Agnholt J, et al. Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2019;156(8):2208–2216.e2201. doi:10.1053/j.gastro.2019.02.005
   PubMed Web of Science ®Google Scholar
• Lightner AL, Dozois EJ, Dietz AB, et al. Matrix-delivered autologous mesenchymal stem cell therapy for refractory rectovaginal Crohn’s fistulas. Inflamm Bowel Dis. 2020;26(5):670–677. doi:10.1093/ibd/izz215
   PubMed Web of Science ®Google Scholar
• Nikolic M, Stift A, Reinisch W, et al. Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn’s disease. Colorectal Dis. 2021;23(1):153–158. doi:10.1111/codi.15324
   PubMed Web of Science ®Google Scholar
• Cho YB, Park KJ, Yoon SN, et al. Long-term results of adipose-derived stem cell therapy for the treatment of Crohn’s fistula. Stem Cells Transl Med. 2015;4(5):532–537. doi:10.5966/sctm.2014-0199
   PubMed Web of Science ®Google Scholar
• Ciccocioppo R, Gallia A, Sgarella A, et al. Long-term follow-up of Crohn disease fistulas after local injections of bone marrow–derived mesenchymal stem cells. Mayo Clin Proc. 2015;90(6):747–755. doi:10.1016/j.mayocp.2015.03.023
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Guadalajara H, Rubio-Perez I, et al. Recurrent anal fistulae: limited surgery supported by stem cells. World J Gastroenterol. 2015;21(11):3330–3336. doi:10.3748/wjg.v21.i11.3330
   PubMed Web of Science ®Google Scholar
• Park KJ, Ryoo S-B, Kim JS, et al. Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn’s disease: a pilot clinical trial. Colorectal Dis. 2016;18(5):468–476. doi:10.1111/codi.13223
   PubMed Web of Science ®Google Scholar
• García-Arranz M, Herreros MD, González-Gómez C, et al. Treatment of Crohn’s-related rectovaginal fistula with allogeneic expanded-adipose derived stem cells: a phase I-IIa clinical trial. Stem Cells Transl Med. 2016;5(11):1441–1446. doi:10.5966/sctm.2015-0356
   PubMed Web of Science ®Google Scholar
• Wainstein C, Quera R, Fluxá D, et al. Stem cell therapy in refractory perineal Crohn’s disease: long-term follow-up. Colorectal Dis. 2018;20(3):O68–O75. doi:10.1111/codi.14002
   PubMed Web of Science ®Google Scholar
• Knyazev OV, Fadeeva NA, Kagramanova AV, et al. Stem cell therapy for perianal Crohn’s disease. Ter Arkh. 2018;90(3):60–66. doi:10.26442/terarkh201890360-66
   PubMed Web of Science ®Google Scholar
• Herreros MD, Garcia-Olmo D, Guadalajara H, et al. Stem cell therapy: a compassionate use program in perianal fistula. Stem Cells Int. 2019;2019:6132340. doi:10.1155/2019/6132340
   PubMed Web of Science ®Google Scholar
• Zhou C, Li M, Zhang Y, et al. Autologous adipose-derived stem cells for the treatment of Crohn’s fistula-in-ano: an open-label, controlled trial. Stem Cell Res Ther. 2020;11(1):124. doi:10.1186/s13287-020-01636-4
   PubMed Web of Science ®Google Scholar
• Laureti S, Gionchetti P, Cappelli A, et al. Refractory complex Crohn’s perianal fistulas: a role for autologous microfragmented adipose tissue injection. Inflamm Bowel Dis. 2020;26(2):321–330. doi:10.1093/ibd/izz051
   PubMed Web of Science ®Google Scholar
• Melmed GY, Pandak WM, Casey K, et al. Human placenta-derived cells (PDA-001) for the treatment of moderate-to-severe Crohnʼs disease. Inflamm Bowel Dis. 2015;21(8):1809–1816. doi:10.1097/mib.0000000000000441
   PubMed Web of Science ®Google Scholar
• Dhere T, Copland I, Garcia M, et al. The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn’s disease - a Phase 1 trial with three doses. Aliment Pharmacol Ther. 2016;44(5):471–481. doi:10.1111/apt.13717
   PubMed Web of Science ®Google Scholar
• Knyazev OV, Parfenov AI, Konoplyannikov AG, Boldyreva ON. Мезенхимальные стволовые клетки в комбинированном лечении язвенного колита [Use of mesenchymal stem cells in the combination therapy of ulcerative colitis]. Ter Arkh. 2016;88(2):44–48. Russian. doi:10.17116/terarkh201688244-48
   PubMed Web of Science ®Google Scholar